Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants

Summary

This study is designed to evaluate the safety and efficacy of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) in participants experiencing treatment-refractory acute GVHD, Grades III-IV, that is refractory to standard first-line therapies and at least one second-line therapy.

Timeline

Start

2005-11-18

Primary completion

2006-04-25

Completion

2007-02-08

Drugs

Indications